Antifibrotic properties of botanicals in chronic liver disease

Hepato-Gastroenterology

Volumn 49, Issue 46, 2002, Pages 1102-1108

  Stickel, Felix ^a   Brinkhaus, B ^a   Krahmer N ^a   Seitz, H K ^a   Hahn, E G ^a   Schuppan, D ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Antifibrotic drugs; Colchicine; Extracellular matrix; Liver fibrosis; Medicinal herbs; Procollagee type III N propeptide; Salvia rniltiorrhiza; Sho saiko to; Silymarin; Traditional Chinese medicine; Trans resveratrol

Indexed keywords

ALPHA INTERFERON; ANTIBODY; BUPLEURUM ROOT; COLCHICINE; COMPOUND 861; FRUCTUS JUJUBAE EXTRACT; GINGER EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; GLYCYRRHIZAE RADIX EXTRACT; HERBACEOUS AGENT; LIV 52; PENTOXIFYLLINE; PHOSPHATIDYLCHOLINE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; RESVERATROL; SALVIA MILTIORRHIZA EXTRACT; SCATTER FACTOR; SCUTELLARIAE RADIX; SCUTELLARIAE RADIX EXTRACT; SILYMARIN; TRANSFORMING GROWTH FACTOR BETA1 ANTIBODY; TUBER PINELLIAE EXTRACT; UNCLASSIFIED DRUG; XIAO CHAI HU TANG; ZINGIBERIS RHIZOMA EXTRACT; ANTIOXIDANT; COLLAGEN; HERBAL COMPOUND 861; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CHRONIC LIVER DISEASE; CLINICAL TRIAL; DRUG DESIGN; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; HERBAL MEDICINE; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER PROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ANIMAL; LIVER; METABOLISM; PATHOLOGY; PHYTOTHERAPY; REVIEW;

ANIMAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CLINICAL TRIALS; COLLAGEN; HUMAN; LIVER; LIVER CIRRHOSIS; PHYTOTHERAPY; PLANT EXTRACTS; ANIMALS; DRUGS, CHINESE HERBAL; HUMANS;

EID: 0036021363     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Cellular and molecular pathobiology, pharmacological intervention, and biochemical assessment of liver fibrosis
2. Liver cirrhosis
3. Inhibition of hepatic fibrogenesis: A review of pharmacological candidates
4. Hepatic fibrosis - Therapeutic strategies
5. Why do people seek treatment by alternative medicine?
6. Saw palmetto extracts for treatment of benign prostatic hyperplasia: A systematic review
7. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis
8. Herbal products for liver diseases: A therapeutic challenge for the new millenium
9. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies
10. Mediators of hepatic fibrogenesis
11. Expression of the gene of the alpha-smooth muscle actin isoform in rat liver and in rat fat storing (Ito) cells
12. Cellular sources of extracellular matrix proteins in normal and fibrotic liver. Studies of gene expression by in situ hybridization
13. Collagen XVIII is localized in sinusoids and basement membrane zones and expressed by hepatocytes and activated stellate cells in fibrotic human liver
14. Hepatocytes are the source of type XVIII endostatin
15. Structure of the extracellular matrix in normal and fibrotic liver: Collagens and glycoproteins
16. Fibrosis and altered matrix synthesis
17. Matrix metalloproteinases and TIMPs: Properties and implications for the rheumatic diseases
18. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis
19. Acute hepatitis induced by greater celandine (Chelidonium majus)
20. Hepatotoxicity of botanicals
21. Hepatotoxicity of herbal remedies
22. Silydianin und silychristin, zwei isomere silymarine aus Silybum marianum (Mariendistel)
23. Poisoning by the deathup fungus (Amanita phalloides): Prognostic factors and therapeutic measures
24. Chemotherapy of Amanita phalloides poisoning with intravenous silibinin
25. Silymarin for the treatment of acute viral hepatitis? Report of a controlled clinical tried
26. Zur wirkung von silymarin bei der behandlung der akuten virushepatitis
27. Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin
28. Effects of silibinin and of a synthetic analogue on a isolated rat hepatic stellate cells and myofibroblasts
29. 4-induced liver cirrhosis by silymarin
30. The pathology of liver injury induced by the chronic administration of alcohol and low dose carbon tetrachloride in Porton rats
31. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats
32. Effect of antifibrotic agent silymarin on liver cell regeneration in a rat model of secondary bilary fibrosis: A morphometric analysis
33. Silymarin downregulates TIMP-1 and collagen I mRNA in rats with secondary biliary cirrhosis
34. Effects of silymarin in alcoholic patients with cirrhosis of the liver: Results of a controlled, double-blind, randomized and multicenter trial
35. Randomized controlled clinical trial of silymarin treatment in patients with cirrhosis of the liver
36. Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
37. A multicenter randomized controlled clinical trial of Sho-saiko-to in chronic active hepatitis
38. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9)
39. Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen expressions in cultured rat hepatic cells
40. Strong antiproliferative effects of baicalein in cultured rat hepatic stellate cells
41. Effects of TJ-9 sho-saiko-to (kampo medicine) on interferon gamma and antibody production specific for hepatitis B virus antigen in patients with type B chronic hepatitis
42. Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet
43. Effects of Sho-saiko-to extract on liver fibrosis in relation to the changes in hydroxyproline and retinoid levels of the liver in rats
44. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats
45. Colchicine: 1998 update
46. Colchicine and the treatment of liver cirrhosis
47. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis
48. A prospective trial of colchicine for primary biliary cirrhosis
49. Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy
50. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid
51. Effects of additional administration of colchicine in ursodeoxychoic acid-treated patients with primary biliary cirrhosis: A prospective randomized study
52. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary billary cirrhosis
53. Evaluation of colchicine therapy in primary billary cirrhosis
54. A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis
55. Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial
56. Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis
57. The natural history of alcoholic cirrhosis: Effect of colchicine
58. A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patients
59. Effect of colchicine on collagen, albumin and transferrin synthesis by cirrhotic rat liver slices
60. Effects of colchicine and colchiceine in a biochemical model of liver injury and fibrosis
61. The role of colchicine in prevention of hepatic cirrhosis induced by carbon tetrachloride
62. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation
63. Trimethylcolchicinic acid decreases liver fibrosis and cholestasis induced by prolonged biliary obstruction in the rat
64. Isolation, identification, and antioxidant activity of three stilbene glucosides newly extracted from vitis vinifera cell cultures
65. Effect of antioxidants, resveratrol, quecetin, and N-acetylcysteine, on the functions of cultured rat heaptic stellate cells and Kupffer cells
66. Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol
67. Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats
68. The effect of herbal compound 861 on mRNA levels for type I, III and IV collagens and TGF in immune complex rat liver fibrosis
69. The effect of herbal cpd 861 on type IV collagen mRNA levels in cultured rat lipocytes
70. Long-term follow-up result of compound Dan Shen granule (861 Chong Fu Ji) in treating hepatofibrosis
71. Pathological study of the therapeutic effect on HBV-related liver fibrosis with herbal compound 861
72. The ayurvedic drug LIV.52 in patients with alcoholic cirrhosis. Results of a prospective, randomized, double-blind, placebo-controlled clinical trial